The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
Cosmetics maker Natura & Co. shelved a plan to switch its primary stock listing to the US from Brazil, as the war in Ukraine and the prospect of surging rates bring wild swings in global equity markets.
The Sao Paulo-based company has decided not to pursue a listing on the New York Stock Exchange for now amid higher volatility and as it focuses on moving forward with the turnaround of Avon Products Inc., chief executive officer Roberto Marques said in an interview. Natura acquired Avon less than three years ago.
“We spent the past few months talking to our shareholders and potential investors, and the conclusion is pretty clear: the US listing makes sense strategically, but maybe timing isn’t right,” Marques said. “We’ll assess the appropriate moment to resume it.”
The company, which also owns the Natura, The Body Shop and Aesop brands, had planned to list on the NYSE, while having Brazilian depositary receipts (BDRs) trade on the Sao Paulo stock exchange — the opposite of the current structure. But that was before the VIX, an indicator of expected volatility in the S&P 500, jumped to the highest level in over a year.
ADVERTISEMENT
Other Brazilian publicly-traded firms mulling a US listing recently included digital lender Banco Inter SA, web services provider Locaweb Servicos de Internet SA and retailer Americanas SA. They were seeking to access a deeper pool of investors and get richer multiples.
By Vinicius Andrade
Learn more:
Beauty Giant Natura Defies Skeptics With Unexpected Margin Gain
Brazil’s Natura & Co delivered a surprise margin gain in the fourth quarter, dealing a blow to sceptics who question whether the cosmetics maker can become a global beauty powerhouse.
The showcase translated the company’s global insights consumer study into scent profiles, technologies and fragrances.
The Estée Lauder-owned premium fragrance house has signed a two-year deal with the actor in a bet to seize more of the men’s market.
From medspas to telemedicine, weight loss drugs are becoming adopted for mainstream cosmetic use.
Mature consumers have long been ignored by the beauty industry. Now a small but growing number of emerging brands are responding to the needs of those over the age of 45 in a bid to cash in on their $15 trillion spending power.